3rd Annual Symposium on Translating Rare Disease Research into Therapies

Honoring Henri Termeer’s Legacy of Catalyzing Impact for Patients

Join us for this dynamic, complimentary and open-to-all session to learn more about translating research through collaboration between academia & industry, the rare disease landscape, and the impact on patients & their families.

• Friday, March 27th 13:00-16:45p CET
• Rijksmuseum Boerhaave
• Lange Sint Agnietenstraat 10, 2312 WC Leiden, The Netherlands

Get your tickets

We are honored to be joined by the following guest speakers:

Lisanne Blauw, Associate, Thuja Capital

Daniel de Boer, Founder & CEO, ProQR

Nettie Buitelaar, Managing Director, Biotech Booster

Inez de Greef, CEO, Treeway

David Meeker, former CEO of Genzyme-a Sanofi company; CEO of Rhythm Pharmaceuticals

Spela Mirosevic, PhD, Founder & President, CTNNB1 Foundation

Felice Verduyn, Partner, EQT Life Sciences

Willem van Weperen, CEO, Pluvia Biotech

This event will be moderated by:

Yael Weiss, CEO, Mahzi Therapeutics

Hans Schikan, Former Top Team Member, Health-Holland

Gijs Santen, Head of Department of Clinical Genetics, Leiden University Medical Center

This is not a hybrid event and will ONLY occur in-person.

Source: Termeer Institute